Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Elpidera

Elpidera?uq=UG6efJS6
2015 FOUNDED
OOB STATUS
Out of Business LATEST DEAL TYPE
Description

Developer of medicines intended for the treatment of rare diseases. The company's medicines uses messenger RNA, enabling doctors to treat rare diseases easily.

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • 320 Bent Street
  • Cambridge, MA 02141
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Elpidera’s full profile, request a free trial.

Elpidera Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Sep-2017 0000 Completed Out of Business
1. Accelerator/Incubator 22-Oct-2015 0000 0000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Elpidera Executive Team (1)

Name Title Board
Seat
Contact
Info
Gregory Licholai MD President